Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsAuthorities have yet to trace the root cause of the radioactive contamination that prompted FDA action against Indonesian shrimp last month.
he National Research and Innovation Agency (BRIN) has declared Indonesian frozen shrimp products safe for consumption and free from radioactive contamination.
The declaration comes after United States authorities rejected a shipment earlier this month over allegations that it contained Cs-137.
It follows rigorous testing, which confirmed that a shrimp shipment previously flagged by US authorities contained no traces of Cesium-137 (Cs-137).
“The government is ensuring swift, measured and transparent handling of the rejection,” Bara Khrisna Hasibuan, expert staff for digital transformation and inter-agency relations at the office of the Coordinating Food Minister, said on Wednesday, as quoted by Kumparan.
The Indonesian Quarantine Agency (Barantin) officially issued release certificates for the products on Tuesday, confirming that they are safe for consumption and cleared for the market.
Upon the shipment's return to Indonesia, a joint team consisting of Customs, Barantin, the Nuclear Energy Regulatory Agency (Bapeten), BRIN and the Maritime Affairs and Fisheries Ministry conducted an inspection.
The tests, carried out using standard laboratory methods, culminated in BRIN’s declaration that the products were free of Cs-137. Barantin’s certificate further confirmed that the nearly 15,000 kilograms of vannamei shrimp were healthy, met all sanitation requirements and were safe for consumption.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.